CLOVIS ONCOLOGY
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Their development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.
CLOVIS ONCOLOGY
Industry:
Biopharma
Founded:
2009-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.clovisoncology.com
Total Employee:
251+
Status:
Active
Total Funding:
145 M USD
Similar Organizations
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Pfizer Venture Investments
Pfizer Venture Investments investment in Venture Round - Clovis Oncology
ProQuest Investments
ProQuest Investments investment in Venture Round - Clovis Oncology
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Venture Round - Clovis Oncology
Domain Associates
Domain Associates investment in Venture Round - Clovis Oncology
Versant Ventures
Versant Ventures investment in Venture Round - Clovis Oncology
Aberdare Ventures
Aberdare Ventures investment in Venture Round - Clovis Oncology
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Clovis Oncology
Abingworth
Abingworth investment in Venture Round - Clovis Oncology
Official Site Inspections
http://www.clovisoncology.com Semrush global rank: 1.73 M Semrush visits lastest month: 13.71 K
- Host name: 208.91.197.27
- IP address: 208.91.197.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Clovis Oncology"
Clovis Oncology - Crunchbase Company Profile
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, …See details»
Clovis Oncology Company Profile | Management and Employees …
Clovis Oncology Profile and History. Founded in 2009, Clovis Oncology is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer …See details»
Clovis Oncology, Inc. Company Profile - Dun & Bradstreet
Company Description: Clovis Oncology is a biopharmaceutical company that acquires, develops, and commercializes innovative anti-cancer agents in the US, Europe, and additional …See details»
Clovis Oncology Company Profile - Office Locations, Competitors …
Feb 21, 2023 Clovis Oncology has 4 employees across 11 locations and $148.76 m in annual revenue in FY 2021. See insights on Clovis Oncology including office locations, competitors, …See details»
Clovis Oncology Information - RocketReach
Clovis Oncology is advancing the fight against cancer. Founded in 2009, Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing and …See details»
Clovis Oncology, Inc. · Suite 100, 5500, Flatiron Parkway
CLOVIS ONCOLOGY, INC. is an entity in Boulder, Colorado registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The entity was registered …See details»
Company Profile for Clovis Oncology - Business Wire
Feb 10, 2012 Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., E Company Profile …See details»
Clovis Oncology - The Org
Clovis Oncology is advancing the fight against cancer. Founded in 2009, Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, …See details»
Clovis Oncology - Company Profile & Staff Directory - ContactOut
Clovis Oncology is advancing the fight against cancer. Founded in 2009, Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing and …See details»
Clovis Oncology CEO and Key Executive Team | Craft.co
Clovis Oncology's Executive Vice President of Human Resources is Ann Bozeman. Other executives include Robert W. Azelby, Director; Paul E. Gross, Executive Vice President and …See details»
Clovis Oncology, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Clovis Oncology, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Clovis Oncology Company Overview, Contact Details
Clovis Oncology. Biotechnology Research Colorado, United States 201-500 Employees. Clovis Oncology is advancing the fight against cancer. Founded in 2009, Clovis Oncology is a …See details»
Clovis Oncology - Contacts, Employees, Board Members
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments. ... Experience the new Crunchbase, powered by AI . …See details»
Clovis Oncology Board of Directors, Key People and Executives ...
Clovis Oncology, Inc. engages in the acquisition, development, and commercialization of anti-cancer agents. Its marketed product, Rubraca, seeks to treat patients with deleterious BRCA …See details»
Clovis Oncology - Funding, Financials, Valuation & Investors
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments. New. Resources. Advanced Search. ... How much funding …See details»
Clovis Oncology finally throws in the towel, files for bankruptcy
Dec 12, 2022 The writing has been on the wall for months, and, now, Clovis Oncology has officially thrown in the towel and filed for Chapter 11 bankruptcy protection. The proceedings …See details»
Cancer drugmaker Clovis files for bankruptcy, hit by falling sales
Dec 12 (Reuters) - U.S. drugmaker Clovis Oncology Inc , opens new tab on Sunday filed for bankruptcy protection in Delaware, hit by a fall in sales of its cancer drug and challenges in …See details»
Clovis Oncology, Inc. Receives License for Worldwide ... - Pfizer
Jun 2, 2011 “Clovis Oncology is the ideal choice to continue the development and commercialization of PF-01367338,” said Garry Nicholson, President and General Manager, …See details»
Clovis Oncology, Inc. (Clovis Oncology, Inc.) - 药物管线_专利_临床 …
了解Clovis Oncology, Inc. (Clovis Oncology, Inc.)公司的药物管线，治疗领域，技术平台，以及它的47项临床试验, 58篇新闻和53篇文献，疾病领域:肿瘤，内分泌与代谢疾病，神经系统疾病， …See details»
Enzalutamide in patients with high-risk biochemically recurrent ...
2 days ago Of the total EMBARK population (N = 1068), 853 patients (80%) met the EAU high-risk BCR definition (post RP: all patients [PSADT < 12 months]; post RT: patients with a GS > …See details»